NCT01994629View on ClinicalTrials.gov

Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers

PHASE2CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

October 31, 2014

Conditions
Meningococcal Disease
Interventions
BIOLOGICAL

MenACWY-CRM

MenACWY-CRM

BIOLOGICAL

MenACWY-TT

MenACWY-TT

Trial Locations (4)

16043

Dipartimento di Prevenzione S C Igiene e Sanita Pubblica, Chiavari

28100

Ospedale Maggiore della Carita, Novara

50139

AOU Meyer Dip Scienze per la Salute della Donna e Bambino, Florence

07100

ASL Sassari 1 Servizio Igiene Pubblica, Sassari

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY